EPB110 Weight gain after antiretroviral therapy initiation in people living with HIVE-posterWeight gain
EPB111 Can ART switch mitigate or reverse INSTI-related weight or BMI gain in at-risk people living with HIV-1?E-posterWeight gain
EPB112 Switching ART Regimens is associated with greater weight gain in people living with HIVE-posterWeight gain
EPB113 Perceptions of health, body size and nutritional risk factors for obesity among people with and without HIV in South AfricaE-posterWeight gain
EPB114 Weight change when discontinuing integrase strand transfer inhibitors in people living with HIVE-posterWeight gain
EPB115 Weight gain after non-nucleoside reverse transcriptase-to-integrase inhibitor switch in the United StatesE-posterWeight gain
EPB116 Change in weight and BMI associated with switching to bictegravir/emtricitabine/tenofovir alafenamide vs. a dolutegravir-based regimen among a prospective longitudinal cohort of virologically suppressed adults living with HIVE-posterWeight gain
EPB117 Preferences for weight gain compared with other antiretroviral therapy side effects among people living with HIV: a discrete choice experimentE-posterWeight gain
EPB118 Longitudinal analysis of weight change in HIV-1 treatment-naïve and -experienced people living with HIV (PLWH) initiating/switching to an NNRTI- or InSTI-based antiretroviral therapy in four large cohort studiesE-posterWeight gain
EPB119 Weight changes and pregnancy outcomes among pregnant people living with HIV in use of integrase inhibitors initiated before or after conception: a cohort studyE-posterWeight gain
51 - 60 of 2485 items